4.87
price down icon2.99%   -0.15
after-market Handel nachbörslich: 4.88 0.010 +0.21%
loading

Sellas Life Sciences Group Inc Aktie (SLS) Neueste Nachrichten

pulisher
May 05, 2026

SLS stock kicks off week in green: CEO flags role in EU biotech policy talks that could impact drug approvals - MSN

May 05, 2026
pulisher
May 04, 2026

SLS Stock Kicks Off Week In Green: CEO Flags Role In EU Biotech Policy Talks That Could Impact Drug Approvals - Stocktwits

May 04, 2026
pulisher
May 03, 2026

SLS stock slips after-hours as cancer pipeline silence frustrates retail — China licensing fight now in spotlight - MSN

May 03, 2026
pulisher
May 02, 2026

SLS Stock Tests $5 Again: Retail Targets ‘No’ Vote On 20M Share Dilution Push Before AML Trial Results - Stocktwits

May 02, 2026
pulisher
May 02, 2026

SLS stock gains momentum: NVDA, MSFT investor loads up ahead of AML trial milestone trigger - MSN

May 02, 2026
pulisher
May 01, 2026

Sellas Life Sciences draws significant retail buzz as traders eye REGAL phase 3 catalyst – SLS stock soars 15% - MSN

May 01, 2026
pulisher
May 01, 2026

SLS News | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - ChartMill

May 01, 2026
pulisher
Apr 30, 2026

SLS stock sparks retail buzz ahead of AACR presentation on experimental cancer therapy - MSN

Apr 30, 2026
pulisher
Apr 30, 2026

SLS stock jumps premarket: US investor Dagco boosts stake by 78% ahead of fresh cancer drug data reveal - MSN

Apr 30, 2026
pulisher
Apr 30, 2026

SLS Forecast, Price Target & Analyst Ratings | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - ChartMill

Apr 30, 2026
pulisher
Apr 29, 2026

SLS stock jumps overnight: ‘potent’ AML drug data ahead of cancer summit fuels fresh momentum - MSN

Apr 29, 2026
pulisher
Apr 29, 2026

SELLAS Life Sciences Group (SLS) price target increased by 15.38% to 10.20 - MSN

Apr 29, 2026
pulisher
Apr 29, 2026

SELLAS LIFE SCIENCES GROUP, INC. (SLS) - MSN

Apr 29, 2026
pulisher
Apr 29, 2026

SLS stock rises premarket ahead of cancer summit this month – investors eye phase 3 AML trial milestone - MSN

Apr 29, 2026
pulisher
Apr 29, 2026

SELLAS Life Sciences Group (SLS) price target increased by 26.83% to 8.84 - MSN

Apr 29, 2026
pulisher
Apr 28, 2026

SLS Stock Gains Momentum: NVDA, MSFT Investor Loads Up Ahead Of AML Trial Milestone Trigger - Stocktwits

Apr 28, 2026
pulisher
Apr 28, 2026

SLS stock jumps overnight: CEO doubles down on ‘steadfast’ confidence in AML drug and pushes for 20M share plan approval - MSN

Apr 28, 2026
pulisher
Apr 27, 2026

SLS stock rallies ahead of AML trial readout — 'Pharma Bro' Martin Shkreli says he's still 'very bearish,' predicts drug will fail - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

SLS Stock Holds Support As Cash Pile Fuels Biotech Bounce - StocksToTrade

Apr 27, 2026
pulisher
Apr 27, 2026

Wall Street analysts think SELLAS Life Sciences Group, Inc. (SLS) could surge 66.09%: Read this before placing a bet - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

SELLAS Life Sciences falls for fourth straight session — what’s driving the sell-off? - MSN

Apr 27, 2026
pulisher
Apr 26, 2026

Sellas Life Sciences Stock In Spotlight After Institutional Investor Exercises Existing Warrants - MSN

Apr 26, 2026
pulisher
Apr 26, 2026

SLS Stock Jumps Overnight: CEO Doubles Down On ‘Steadfast’ Confidence In AML Drug And Pushes For 20M Share Plan Approval - Stocktwits

Apr 26, 2026
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
Kapitalisierung:     |  Volumen (24h):